The popularity of Glucagon-like peptide 1 (GLP-1) agonists, drugs which mimic a hormone to stimulate insulin production, has drastically increased since the U.S FDA’s approval of Ozempic in 2017. These drugs can help control type two diabetes by lowering blood sugar when it rises, for example, after meals. However, despite their benefits, these drugs can cause several serious side effects, such as depression and suicidal thoughts. GLP-1’s are also extremely costly, with a monthly supply costing up to $1,350 in America.
RFK Jr., Bash clash in heated interview: ‘This is not productive’
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and CNN’s Dana Bash clashed over vaccine safety and COVID-19 in a heated interview on
